RT @jitcancer: On #WomensDay #IWD2020 we are excited to highlight great work from our colleague Dr. Elena Verzoni @EVerzoni @IstTumori on t…
On #WomensDay #IWD2020 we are excited to highlight great work from our colleague Dr. Elena Verzoni @EVerzoni @IstTumori on the Italian experience of PD1 Ab in refractory #RCC #NeedHerScience #SheInspiresMe https://t.co/zSMCi5rNtI
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program https://t.co/UBb9nsvMLJ
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse e... - PubMed - NCBI https://t.co/MZYe7nMtSY
RT @sitcancer: #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and assoc…
#JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program https://t.co/wiCsvoypFo
#JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program https://t.co/wiCsvoypFo
RT @myTomorrows: Italian EA study on mRCC -https://t.co/23pQYqhXfz - highlights the importance of RWD, as EAP showed lower AE’s vs. CT -…
RT @myTomorrows: Italian EA study on mRCC -https://t.co/23pQYqhXfz - highlights the importance of RWD, as EAP showed lower AE’s vs. CT -…
Italian EA study on mRCC -https://t.co/23pQYqhXfz - highlights the importance of RWD, as EAP showed lower AE’s vs. CT - Understanding safety results in the routine clinical practice is vital, and provides valuable insights- #mrCC #KCSM #expandedaccess #R
RT @sitcancer: New #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and a…
RT @sitcancer: New #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and a…
RT @sitcancer: New #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and a…
RT @sitcancer: New #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and a…
New #JITC Research: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program https://t.co/wiCsvoypFo